Ignite Creation Date:
2024-05-05 @ 4:51 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00324155
Status:
COMPLETED
Last Update Posted:
2014-11-02
First Post:
2006-05-08
Brief Title:
Dacarbazine and Ipilimumab vs Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-08
Start Date Type:
None
Primary Completion Date:
2011-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-10
Completion Date Type:
ACTUAL
First Submit Date:
2006-05-08
First Submit QC Date:
May 9 2006
Study First Post Date:
2006-05-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2014-03-10
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2011-01-29
Disp First Submit QC Date:
June 17 2011
Disp First Post Date:
2011-06-20
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2014-10-24
Last Update Post Date:
2014-11-02
Last Update Post Date Type:
ESTIMATED